<DOC>
	<DOCNO>NCT01928901</DOCNO>
	<brief_summary>Proof concept : Superiority Bronchipret Sinupret placebo respect mucociliary clearance</brief_summary>
	<brief_title>Trial With Bronchipret Sinupret Evaluate Acceleration Mucociliary Clearance ( MCC )</brief_title>
	<detailed_description />
	<mesh_term>Thymol</mesh_term>
	<criteria>1 . Volunteers give sign declaration consent sign data protection declaration 2 . Male female volunteer 25 40 year 3 . Current smoker ( 520 cigarette per day since 5 year least ) 4 . Ability taste sweetness saccharin 5 . Perception sweetness within 30 minute placement saccharin behind nasal valve 1 . Ciliary dyskinesia 2 . Cystic fibrosis 3 . COPD/emphysema 4 . Asthma 5 . Chronic rhinosinusitis 6 . Acute respiratory tract infection within last 6 week prior enrolment 7 . Septal sinus surgery 8 . Symptomatic allergic rhinitis 9 . Known allergic rhinitis 10 . Treatment notpermitted previous concomitant therapy 11 . History snuff consumption longer 1 month intranasal consumption recreational drug cocaine heroin longer 1 month 12 . Any disease condition might affect safety subject trial , accord investigator 's judgement</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>